Pharma-Biotech Capital Construction Investment Mid-Year Snapshot: 2012 Project Starts Near $15 Billion, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 06/12/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2012 almost halfway complete, the North American is holding its own. In January 2012, the industry as a whole had more than $17 billion in reported capital and maintenance projects scheduled to kick off throughout the year. Six months later, that total has dropped to just less $15 billion, or $14.7 billion to be exact.
Other companies featured (NYSE:BAX), (NYSE:ABT)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.06.2012 - 04:20 Uhr
Sprache: Deutsch
News-ID 1123225
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma-Biotech Capital Construction Investment Mid-Year Snapshot: 2012 Project Starts Near $15 Billion, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
